Latest Insights

Sharper Thinking for Health Plans
That Can't Afford to Guess

Analysis, playbooks, and research for government-sponsored health plans navigating a faster, more competitive market.

Insights

Q3 2026 health plan earnings: beats and raises across seven payers, while the 2027 Medicare Advantage maps pull apart

This Q3 2026 health plan earnings report from HealthWorksAI compares UnitedHealth Group, CVS Health (Aetna), Elevance Health, Centene, Humana, Molina Healthcare and Alignment Healthcare, covering earnings calls held October 13 through November 6, 2026, and reads each against HealthWorksAI’s 2027 plan, benefit and enrollment data, alongside public commentary on the health of the industry.

Read More →
Humana Q3 2026 earnings
Insights

Humana Q3 2026 earnings: a beat, a raised outlook and near-record Star Ratings, as the 2027 map shrinks

Humana reported an adjusted loss of $0.70 per share against about a $1.00 loss expected, raised its 2026 adjusted EPS outlook to at least $9.50 and reported a member-weighted Star rating of 4.17 for bonus year 2028. It filed 861 Medicare Advantage plans for 2027, down from 887, while exiting 61 counties. This page reads the earnings call, the stock reaction and HealthWorksAI’s 2027 plan and benefit data together.

Read More →
Insights

CVS Health Q3 2026 earnings: a broad beat and a raised outlook, as CVS plans to split into two companies

CVS Health reported adjusted EPS of $2.09 against $1.65 expected, raised its 2026 outlook to at least $8.20, and announced plans to separate into two public companies by the first half of 2028. It also filed 654 Medicare Advantage plans for 2027, up from 642, while exiting 127 counties. This page reads the earnings call, the stock reaction and HealthWorksAI’s 2027 plan, benefit and enrollment data together.

Read More →
Insights

Margin or members? What our Medicare Advantage enrollment predictions says about the trade-off as you begin 2028 product designs

Based upon the newly released plan designs and existing AEP market conditions, we have predicted February enrollment results for 161 payers. Nationally, we see a minor contraction in the total number of individual MA covered lives. However, we drill into the nuances of geography, product and network competitiveness, brand and distribution to support 2028 bid decisions.

Read More →

Be the first to read our resources.

The healthcare payer industry is changing rapidly—and our resources help you stay on top of it all. Sign up to get new insights, success stories, and more, sent right to your inbox.

You're on the list.

Thanks for subscribing — keep an eye on your inbox for our next resource.